Literature DB >> 11456480

A ParE-ParC fusion protein is a functional topoisomerase.

L S Lavasani1, H Hiasa.   

Abstract

Type II topoisomerases are responsible for DNA unlinking during DNA replication and chromosome segregation. Although eukaryotic enzymes are homodimers and prokaryotic enzymes are heterotetramers, both prokaryotic and eukaryotic type II topoisomerases belong to a single protein family. The amino- and carboxyl-terminal domains of eukaryotic enzymes are homologous to the ATP-binding and catalytic subunits of prokaryotic enzymes, respectively. Topoisomerase IV, a prokaryotic type II topoisomerase, consists of the ATP-binding subunit, ParE, and the catalytic subunit, ParC. We have joined the coding regions of parE and parC in frame and constructed a fusion protein of the two subunits of topoisomerase IV. This fusion protein, ParEC, can catalyze both decatenation and relaxation reactions. The ParEC protein is also capable of decatenating replicating daughter DNA molecules during oriC DNA replication in vitro. Furthermore, the fusion gene, parEC, complements the temperature-sensitive growth of both parC and parE strains, indicating that the ParEC protein can substitute for topoisomerase IV in vivo. These results demonstrate that a fusion protein of the two subunits of topoisomerase IV is a functional topoisomerase. Thus, a heterotetrameric type II topoisomerase can be converted into a homodimeric type II topoisomerase by gene fusion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456480     DOI: 10.1021/bi0155201

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Replacement of ParC alpha4 helix with that of GyrA increases the stability and cytotoxicity of topoisomerase IV-quinolone-DNA ternary complexes.

Authors:  Emily S Pfeiffer; Hiroshi Hiasa
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Type IIA topoisomerase inhibition by a new class of antibacterial agents.

Authors:  Benjamin D Bax; Pan F Chan; Drake S Eggleston; Andrew Fosberry; Daniel R Gentry; Fabrice Gorrec; Ilaria Giordano; Michael M Hann; Alan Hennessy; Martin Hibbs; Jianzhong Huang; Emma Jones; Jo Jones; Kristin Koretke Brown; Ceri J Lewis; Earl W May; Martin R Saunders; Onkar Singh; Claus E Spitzfaden; Carol Shen; Anthony Shillings; Andrew J Theobald; Alexandre Wohlkonig; Neil D Pearson; Michael N Gwynn
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

3.  Structural basis for the MukB-topoisomerase IV interaction and its functional implications in vivo.

Authors:  Seychelle M Vos; Nichole K Stewart; Martha G Oakley; James M Berger
Journal:  EMBO J       Date:  2013-10-04       Impact factor: 11.598

4.  Interplay between type 1A topoisomerases and gyrase in chromosome segregation in Escherichia coli.

Authors:  Valentine Usongo; Cynthia Tanguay; Flora Nolent; Jill Egbe Bessong; Marc Drolet
Journal:  J Bacteriol       Date:  2013-02-08       Impact factor: 3.490

Review 5.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

6.  Functions of a GyrBA fusion protein and its interaction with QnrB and quinolones.

Authors:  Chunhui Chen; Regis Villet; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

7.  Structural insight into negative DNA supercoiling by DNA gyrase, a bacterial type 2A DNA topoisomerase.

Authors:  Julie Papillon; Jean-François Ménétret; Claire Batisse; Reynald Hélye; Patrick Schultz; Noëlle Potier; Valérie Lamour
Journal:  Nucleic Acids Res       Date:  2013-06-26       Impact factor: 16.971

8.  A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function.

Authors:  Allyn J Schoeffler; Andrew P May; James M Berger
Journal:  Nucleic Acids Res       Date:  2010-07-31       Impact factor: 16.971

9.  Topoisomerases I and III inhibit R-loop formation to prevent unregulated replication in the chromosomal Ter region of Escherichia coli.

Authors:  Julien Brochu; Émilie Vlachos-Breton; Sarah Sutherland; Makisha Martel; Marc Drolet
Journal:  PLoS Genet       Date:  2018-09-17       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.